Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-26 to 2022-04-27
Current total value of award: $145.06
Description: 4557121934!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML